Figure 2From: Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study Hospitalisations by baseline SHPT parameters, all 10 countries. CVD, cardiovascular disease; iPTH, intact parathyroid hormone; PTX, parathyroidectomy; SHPT, secondary hyperparathyroidism. *Mean during 3-month baseline period. †CVD-, fracture- or PTX-related.Back to article page